1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Top Countries

About 1800 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2024

  • $ 3000
  • May 2020
  • 195 pages

Global Immuno-Oncology Market, By Major Indications ##. ## Head & Neck Cancer ##. ## Lung Cancer ##. ## Melanoma ##. ## Lymphoma ##. ## Leukemia ##. ## Others ##.

  • Lymphoma
  • Oncology
  • Therapy
  • World
  • Market Size

Global Mantle Cell Lymphoma Therapeutics Market 2019-2023

  • $ 2500
  • July 2019
  • 131 pages

Global Mantle Cell Lymphoma Therapeutics Market: About this market Mantle cell lymphoma therapeutics are available in combination therapy and monotherapy.

  • Lymphoma
  • Therapy
  • World
  • Demand
  • Forecast

Global Follicular Lymphoma Therapeutics Market 2018-2022

  • $ 2500
  • October 2018
  • 105 pages

Hoffmann-La Roche • Gilead • Merck About Follicular Lymphoma Follicular lymphoma is a subtype of B-cell non-Hodgkin lymphoma (NHL).

  • Lymphoma
  • Therapy
  • World
  • Market Size

The 2021-2026 World Outlook for Lymphoma Therapeutics

  • $ 995
  • November 2019
  • 299 pages

This study covers the world outlook for lymphoma therapeutics across more than ## countries.

  • Cancer
  • Lymphoma
  • Pathology
  • World
  • Demand

Global Burkitt Lymphoma Therapeutics Market 2018-2022

  • $ 2500
  • September 2018
  • 109 pages

Hoffmann-La Roche • Merck Sharp & Dohme • Novartis • Spectrum Pharmaceuticals About Burkitt Lymphoma Burkitt Lymphoma is one of the rare types of B-cell non-Hodgkin’s lymphoma.

  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market 2018-2022

  • $ 2500
  • October 2018
  • 110 pages

Hoffmann-La Roche • Merck Sharp & Dohme • Novartis • Pfizer • Spectrum Pharmaceuticals About Diffuse Large B-Cell Lymphoma DLBCL is a cancer of B-lymphocytes.

  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Lymphoma Drugs Market 2017-2021

  • $ 2500
  • June 2017
  • 86 pages

The aim of lymphoma treatment is to get rid of the lymphoma cells.

  • Lymphoma
  • World
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

Market Spotlight: Mantle Cell Lymphoma

  • $ 1318
  • November 2019
  • 47 pages

Key Takeaways The analyst estimates that in 2017, there were approximately ##, ## incident cases of mantle cell lymphoma (MCL) worldwide, and forecasts that number to increase to ##, ## incident cases by 2026.

  • Drug Development
  • Lymphoma
  • World

Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

  • $ 2400
  • March 2018
  • 280 pages

Diffuse Large B Cell Lymphoma ##. ## Introduction ##. ## Classification of Diffuse Large B Cell Lymphoma ##.

  • Cancer
  • Lymphoma
  • Therapy
  • World
  • Market Size

Global Bruton’s Tyrosine Kinase (BTK) Inhibitors Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

  • $ 900
  • June 2020
  • 82 pages

B-cell lymphomas can be categorized into aggressive NHL, such as diffuse large B-Cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and burkitt' s lymphoma (BL), and indolent NHL, such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma

  • Autoimmune Disease
  • Lymphoma
  • Therapy
  • World
  • AbbVie Inc.

Pre -packaged Medical Kits And Trays for Saline Prefilled Syringes Market to 2027 - Global Analysis and Forecasts by Product Type; End User, and Geography

  • $ 4550
  • June 2019
  • 162 pages

The figure given below shows the revenue generation trends for the lymphoma from 2018 to 2027.

  • CT Scan
  • Lymphoma
  • World
  • Forecast
  • Market Size

Global Immune Checkpoint Inhibitors Market Outlook 2022

  • $ 1800
  • March 2020
  • 130 pages

Application of Immune Checkpoint Inhibitors in Major Indications ##. ## Head & Neck Cancer ##. ## Lung Cancer ##. ## Melanoma ##. ## Lymphoma ##. ## Leukemia ##. ## Others ##.

  • Lymphoma
  • Medical Biotechnology
  • World

GLOBAL AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET FORECAST 2019-2027

  • $ 2500
  • August 2019
  • 139 pages

LYMPHOMA IN THE UNITED STATES 2019 (%) FIGURE ## GLOBAL AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET SHARE BY PRODUCT TYPE, 2018 & 2027 (%) FIGURE ## GLOBAL AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY DEVICES, 2019-2027 ($ MILLION) FIGURE ## GLOBAL AUTOTRANSFUSION DEVICES AND CONS

  • Cancer
  • Lymphoma
  • World

Global Tumor-specific Antigen Market

  • $ 5500
  • May 2019
  • 140 pages

By 2018, immune response for a range of cancers including kidney, lung, brain (especially glioblastoma), breast, cervical, colorectal, lymphoma, melanoma, pancreatic and prostate cancer were under investigation.

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • World

Blood Cancer Therapeutics: Global Markets to 2023

  • $ 5500
  • December 2018
  • 174 pages

This report forecasts the global market by disease area and discusses market data for leukemia, lymphoma and myeloma.

  • Cancer
  • Leukemia
  • Lymphoma
  • Pathology
  • World

Pericardiocentesis Procedures Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • $ 5795
  • March 2020
  • 180 pages

Lymphoma ##. ##. ##. ##.

  • Cardiology
  • Health Services
  • Lymphoma
  • World
  • Forecast

Global Cancer Immunotherapy Market Forecast 2019-2029

  • $ 4374
  • January 2019
  • 194 pages

Global Cancer Immunotherapy Market for Other Cancer types (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma): ($m, AGR%, CAGR%) 2018-2029 Table ##. ##.

  • Cancer Immunotherapy
  • Lymphoma
  • Therapy
  • World
  • Market Size

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis

  • $ 1800
  • August 2018
  • 110 pages

These cancers include leukemia, lymphoma, melanoma, ovarian cancer, and bladder cancer amongst others.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • World

Market Spotlight: Gastrointestinal Stromal Tumor (GIST), Pharma Intelligence

  • $ 1318
  • April 2020
  • 43 pages

lymphoma, and proportion of individuals with TLS, 2017 ## Table ##: Incident cases of TLS in Burkitt’s lymphoma, 2017–## ## Table ##: Marketed drugs for TLS ## Table ##: Parent patents in TLS ## Table ##: Historical global sales, by drug ($m), 2014–## ## Table ##: Forecasted global sa

  • Clinical Trial
  • Drug Development
  • Lymphoma
  • China
  • World
View report >

Global Cancer Statistics

  • April 2020
  • 22 pages

For chronic lymphocytic leukaemia (CLL), rituximab-refractory follicular lymphoma and previously untreated advanced follicular lymphoma.

  • Cancer
  • Lymphoma
  • World
  • Demand
  • Roche Group

Global Oncology Market October 2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on